The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Xu, Huan ^a   Cao, Dayan ^a   Guo, Guoning ^a   Ruan, Zhihua ^a   Wu, Yuzhang ^a   Chen, Yongwen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

B7 superfamily; BTLA; HBV ACLF; HVEM; Immunohistochemistry

Indexed keywords

BIOLOGICAL MARKER; BTLA PROTEIN, HUMAN; HERPESVIRUS ENTRY MEDIATOR; IMMUNOGLOBULIN RECEPTOR; LIGAND; TNFRSF14 PROTEIN, HUMAN;

ACUTE LIVER FAILURE; ARTICLE; BIOPSY; CASE CONTROL STUDY; CHEMISTRY; END STAGE LIVER DISEASE; ENDOTHELIUM CELL; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; HEPATITIS B; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LIVER; MACROPHAGE; METABOLISM; PATHOLOGY; PHENOTYPE; T LYMPHOCYTE; VIROLOGY;

BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; END STAGE LIVER DISEASE; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LIVER; LIVER FAILURE, ACUTE; MACROPHAGES; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES;

EID: 84867376002     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-142     Document Type: Article

References (28)

1. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009, 6:542-553. 10.1038/nrgastro.2009.127, 19652652.
2. Liu Q, Liu Z, Wang T, et al. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroen Hepatol 2007, 22:2101-2106.
3. Liu M, Chan C, McGilvray I, et al. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Rev Mol Med 2001, 2001:1-19.
4. Marsden PA, Ning Q, Fung L, et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003, 112:58-66. 162293, 12840059.
5. Watanabe N, Gavrieli M, Sedy JR, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immuno 2003, 4:670-679.
6. Deppong C, Juehne TI, Hurchla M, et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol 2006, 176:3909-3913.
7. Oya Y, Watanabe N, Owada T, et al. Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator. Arthritis Rheum 2008, 58:2498-2510. 10.1002/art.23674, 2782777, 18668554.
8. Tao R, Wang L, Han R, et al. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J Immunol 2005, 175:5774-5782.
9. Serriari NE, Gondois-Rey F, Guillaume Y, et al. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J Immunol 2010, 185:3140-3148. 10.4049/jimmunol.0902487, 20693422.
10. Sun Y, Brown NK, Ruddy MJ, et al. B and T lymphocyte attenuator tempers early infection immunity. J Immunol 2009, 183:1946-1951. 10.4049/jimmunol.0801866, 2895307, 19587015.
11. Sedy JR, Gavrieli M, Potter KG, et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 2005, 6:90-98.
12. Gavrieli M, Watanabe N, Loftin SK, et al. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem Biophys Res Commun 2003, 312:1236-1243. 10.1016/j.bbrc.2003.11.070, 14652006.
13. Yang C, Chen Y, Guo G, et al. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3. Gut 2012, Jun 9. [Epub ahead of print].
14. Cao D, Xu H, Guo G, et al. Intrahepatic Expression of Programmed Death-1 and its Ligands in Patients with HBV-Related Acute-on-Chronic Liver Failure. Inflammation 2012, Aug 16. [Epub ahead of print].
15. Guo G, Cao D, Xu H, et al. The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure. Pathology Int 2012, 62:665-674.
16. Murphy TL, Murphy KM. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 2010, 28:389-411. 10.1146/annurev-immunol-030409-101202, 20307212.
17. Derré L, Rivals JP, Jandus C, et al. BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. J Clin Invest 2010, 120:157-167. 10.1172/JCI40070, 2799219, 20038811.
18. Pasero C, Speiser DE, Derré L, et al. The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy. Curr Opin Pharmacol 2012, 12:478-485. 10.1016/j.coph.2012.03.001, 22445654.
19. Nascimento C, Bottino A, Nogueira C, et al. Analysis of morphological variables and arterialization in the differential diagnosis of hepatic nodules in explanted cirrhotic livers. Diagn Pathol 2007, 2:51. 10.1186/1746-1596-2-51, 2254375, 18154665.
20. Das P, Jain D, Das A. A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. Diagn Pathol 2007, 2:27. 10.1186/1746-1596-2-27, 1971252, 17662118.
21. Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999, 5:1365-1369. 10.1038/70932, 10581077.
22. Latchman Y, Wood CR, Chernova T, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immuno 2001, 2:261-268.
23. Chapoval AI, Ni J, Lau JS, et al. B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001, 2:269-274. 10.1038/85339, 11224528.
24. Hashiguchi M, Kobori H, Ritprajak P, et al. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counterreceptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci USA 2008, 105:10495-10500. 10.1073/pnas.0802423105, 2492502, 18650384.
25. Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003, 18:849-861. 10.1016/S1074-7613(03)00152-3, 12818165.
26. Prasad DV, Richards S, Mai XM, et al. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003, 18:863-873. 10.1016/S1074-7613(03)00147-X, 12818166.
27. Suh WK, Wang S, Duncan GS, et al. Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol Cell Biol 2006, 26:6403-6411. 10.1128/MCB.00755-06, 1592821, 16914726.
28. Zhu G, Augustine MM, Azuma T, et al. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. Blood 2009, 113:1759-1767. 10.1182/blood-2008-01-133223, 2647680, 19109567.